TrialJournal of thrombosis and thrombolysis2011

Levosimendan reduces plasma cell-free DNA levels in patients with ischemic cardiomyopathy.

Apostolos Zaravinos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.